BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7865538)

  • 21. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
    Chiu SJ; Marcucci G; Lee RJ
    Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery.
    Zhai G; Wu J; Xiang G; Mao W; Yu B; Li H; Piao L; Lee LJ; Lee RJ
    J Nanosci Nanotechnol; 2009 Mar; 9(3):2155-61. PubMed ID: 19435095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis.
    Lee RJ; Low PS
    J Biol Chem; 1994 Feb; 269(5):3198-204. PubMed ID: 8106354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo.
    Nguyen VD; Min HK; Kim CS; Han J; Park JO; Choi E
    Colloids Surf B Biointerfaces; 2019 Jan; 173():539-548. PubMed ID: 30343218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
    Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
    Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate.
    Yoo HS; Park TG
    J Control Release; 2004 Nov; 100(2):247-56. PubMed ID: 15544872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo.
    Huang Y; Yang T; Zhang W; Lu Y; Ye P; Yang G; Li B; Qi S; Liu Y; He X; Lee RJ; Xu C; Xiang G
    Int J Nanomedicine; 2014; 9():4581-95. PubMed ID: 25302024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folate-Modified Poly(malic acid) Graft Polymeric Nanoparticles for Targeted Delivery of Doxorubicin: Synthesis, Characterization and Folate Receptor Expressed Cell Specificity.
    Yang Y; Li N; Nie Y; Sheng M; Yue D; Wang G; Tang JZ; Gu Z
    J Biomed Nanotechnol; 2015 Sep; 11(9):1628-39. PubMed ID: 26485931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation of reversibly cross-linked polyplexes into LPDII vectors for gene delivery.
    Gosselin MA; Guo W; Lee RJ
    Bioconjug Chem; 2002; 13(5):1044-53. PubMed ID: 12236787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes.
    Malhi SS; Budhiraja A; Arora S; Chaudhari KR; Nepali K; Kumar R; Sohi H; Murthy RS
    Int J Pharm; 2012 Aug; 432(1-2):63-74. PubMed ID: 22531856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Clickable" polymer-caged nanobins as a modular drug delivery platform.
    Lee SM; Chen H; O'Halloran TV; Nguyen ST
    J Am Chem Soc; 2009 Jul; 131(26):9311-20. PubMed ID: 19527027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model.
    de Oliveira Silva J; Fernandes RS; Ramos Oda CM; Ferreira TH; Machado Botelho AF; Martins Melo M; de Miranda MC; Assis Gomes D; Dantas Cassali G; Townsend DM; Rubello D; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2019 Oct; 118():109323. PubMed ID: 31400669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of antitumor effect of zoledronic acid entrapped in folate-linked liposome for targeting to tumor-associated macrophages.
    Hattori Y; Yamashita J; Sakaida C; Kawano K; Yonemochi E
    J Liposome Res; 2015; 25(2):131-40. PubMed ID: 25203609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of a novel polymeric material folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine tri-block polymer for dual receptor and pH-sensitive targeting liposome.
    Xia G; An Z; Wang Y; Zhao C; Li M; Li Z; Ma J
    Chem Pharm Bull (Tokyo); 2013; 61(4):390-8. PubMed ID: 23385961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folate receptor targeted biodegradable polymeric doxorubicin micelles.
    Yoo HS; Park TG
    J Control Release; 2004 Apr; 96(2):273-83. PubMed ID: 15081218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells.
    Dixit V; Van den Bossche J; Sherman DM; Thompson DH; Andres RP
    Bioconjug Chem; 2006; 17(3):603-9. PubMed ID: 16704197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy.
    Sudimack JJ; Adams D; Rotaru J; Shukla S; Yan J; Sekido M; Barth RF; Tjarks W; Lee RJ
    Pharm Res; 2002 Oct; 19(10):1502-8. PubMed ID: 12425468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
    Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
    J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance.
    Chen Y; Cheng Y; Zhao P; Zhang S; Li M; He C; Zhang X; Yang T; Yan R; Ye P; Ma X; Xiang G
    Int J Pharm; 2018 May; 542(1-2):266-279. PubMed ID: 29551747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.